Cambridge Healthtech Institute’s Inaugural

Internet of Diagnostic Things
( 使用IoT的诊断 )

Connected Diagnostics: IoT, Sensors, Wearables, and Smartphones Bring Point-of-Care Testing to the Patient

2019年6月17日


The latest advances in biosensors, wearables, Internet of Medical Things, and smartphone capabilities are promising to revolutionize healthcare and drug development by shifting point-of-care diagnostics to the patient, offering novel digital biomarkers for innovating clinical trials, and enabling the next generation of patient-centric personalized medicine. CHI's Inaugural Internet of Diagnostic Things symposium will present the latest advances in connected diagnostics, including connected biosensors, wearables and implantables, smartphone-enabled diagnostics, remote patient monitoring, and digital biomarkers.

Final Agenda

Stay on to attend Tuesday, June 18 - Wednesday, June 19

Immuno-Oncology Biomarkers 1: Predictive Biomarkers and Companion Diagnostics or
Clinical and Translational Biomarkers

Wednesday, June 19 - Thursday, June 20

Immuno-Oncology Biomarkers 2: Immune Profiling and Immune Monitoring

6月17日(一)

8:30 am Registration Open and Morning Coffee

CONNECTED DIAGNOSTICS: IOT, SENSORS AND WEARABLES BRING POINT-OF-CARE DX TO THE PATIENT

9:00 Welcome and Opening Remarks

Christopher M. Hartshorn, PhD, Program Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health

9:10 Towards Smart and Connected Point of Care Molecular Diagnostics of Infectious Diseases

Changchun Liu, PhD, Associate Professor, Biomedical Engineering Department, University of Connecticut

Smartphones have a growing and pervasive influence on our daily life. Especially with the rapid development of microfluidics technology, the incorporation of microfluidics technology with smartphone-based detection technology will create a new paradigm shift towards affordable, smart and connected health monitoring. In this talk, I will introduce our molecular diagnostic chips, smart connected devices and their applications in cervical cancer screening and infectious disease detection at the point of care.

9:40 Portability and Security for the Next Generation Point-of-Care Diagnostics

Yuksel Temiz, PhD, Research Staff Member, IBM Research-Zurich

Diagnostic technologies based on microfluidics and IoT represent a strong opportunity for providing sensitive, low-cost, rapid and connected diagnostics at the point-of-care. In this presentation, I will share our vision on a portable and connected diagnostic platform, which uses capillary-driven microfluidics and compact peripherals enabling communication with a smartphone. I will also discuss our recent efforts on the development of security features that can protect diagnostic tests from counterfeiting.

10:10 Using AI to Enable IOT and Diagnostics Devices to Deliver Personalized Care at Global Scale

Ting Shih, MBA, MS, CEO & Founder, ClickMedix

Technological advances made possible rapid emergence of point-of-care devices. However, at scale, each device needs to work within healthcare workflows, policies, and clinical guidelines to improve the health of patients. Having worked in more than 20 countries, in this talk, Ting Shih will go over an end-to-end roadmap for deploying IOT devices, integrated with clinical protocols, personalized care plans, and payment schemes to maximize the impact of IOTs and demonstrate improvement on patient health outcomes. With the use of AI, the impact of IOTs can be magnified throughout patient populations.

10:40 Networking Coffee Break

CONNECTED DIAGNOSTICS: IOT, SENSORS AND WEARABLES BRING POINT-OF-CARE DX TO THE PATIENT (CONT.)

11:10 Wearables, Ingestibles, Invisibles - New Diagnostic Platforms Enabled by Silicon and AI

Chris Van Hoof, PhD, Senior Director, Connected Health Solutions, Imec

How are highly-sensitive, AI-powered, clinical-grade diagnostics and wearables being used for early disease detection, personalized treatment and prevention? Find out how our wearable health patches can serve the field of nephrology. How fast eye tracking glasses play a role in neurodegenerative disease management. How ingestible sensors monitor gastrointestinal disorders. And how wearable sensors assist the psychiatrist. These tech and AI innovations kickstarted a health tech revolution.

11:40 Wearable Sensors and Their Importance in the Complete Digital Health Solution

Brian Murphy, PhD, Director, Product Development, Connected Sensors, Philips Medical Systems

12:10 pm Sponsored Presentation (Opportunity Available)

12:40 Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own

1:10 Session Break

CONNECTED SENSORS AND WEARABLES FOR REMOTE PATIENT MONITORING AND CLINICAL TRIALS

 

1:55 Piloting a Living Lab for Evaluation and Development of Novel Digital Biomarkers

Steven Richards, PharmD, Investigator, Biomarker Development, Novartis Institutes for BioMedical Research

The incorporation of digital biomarkers in clinical trials offers the possibility of replacing poor endpoints with more sensitive measures, while lowering cost and patient burden. Prior to implementing new technologies in clinical trials, it is important to conduct feasibility studies in realistic deployment environments. Living laboratories are simulated real-world environments equipped with embedded sensors, which allow us to establish ecological validity of digital biomarkers measured at-home.

2:25 Solving the ‘Last Mile’ Problem in the Delivery of Cancer Care: Cyber-Physical Systems and Smart Connected Health to Support Clinical Decision Making

Christopher M. Hartshorn, PhD, Program Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health

Cancer patients disconnected from resource intensive cancer centers face challenges beyond simply the disease they are dealing with. This ‘last mile’ problem of healthcare delivery is becoming more tractable with modern broadband connectivity and sensors. This talk will discuss major barriers from the patient and clinical workflow/integration sides as well as synergistic efforts across NCI and other agencies attempting to enable these tools for clinical applications and decision support.

2:55 Networking Refreshment Break

3:15 PANEL DISCUSSION: Future of Connected Diagnostics

Moderator: Christopher M. Hartshorn, PhD, Program Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health

Panelists: Speakers of the day

Discussion topics include:

  • What are the emerging applications of IoT in diagnostics and remote patient monitoring?
  • What is needed for patient compliance and increased adoption?
  • What IT capabilities are needed for “big data” analysis? Opportunities for AI and machine learning?
  • How can this technology benefit big pharma? Applications in clinical trials, patient engagement, and digital therapeutics?
  • How can connected diagnostics serve as digital biomarkers in clinical trials?

4:45 Close of Symposium


5:00 Dinner Short Course Registration

5:30 Dinner Short Course*

*Separate registration required.

Stay on to attend Tuesday, June 18 - Wednesday, June 19

Immuno-Oncology Biomarkers 1: Predictive Biomarkers and Companion Diagnostics or
Clinical and Translational Biomarkers

Wednesday, June 19 - Thursday, June 20

Immuno-Oncology Biomarkers 2: Immune Profiling and Immune Monitoring

* 活动内容有可能不事先告知作更动及调整。

Choose your language
Chinese
Japanese
Korean
English





免费电子邮件通知服务